crackdown on glp 1 meds FDA issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Pharma News Weekly: API Prices

At Embla, we've developed a different model one that delivers the weight loss outcomes people want, while drastically reducing long-term medication use

Ready to give your weight-loss journey a smarter boost

Theres concern about the safety of different salt formulations, says Diana Isaacs, PharmD, BCADM, CDCES, an endocrinology clinical pharmacy specialist at the Cleveland Clinic Endocrinology and Metabolism Institute in Cleveland

Claims of fat-dissolving power stretch what any ACV gummy can achieve

What the evidence suggests: In patients with fatty liver disease, low-dose Semaglutide may enhance physical function and energy levels